(5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 2-ethyl-4-(1-hydroxy-1-methylethyl)-1-{4-[2-(trityltetrazole-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate → HCID 178437627, compound
Reaction equation
[CH2:1]([C:3]1[N:4]([CH2:23][C:24]2[CH:29]=[CH:28][C:27]([C:30]3[CH:35]=[CH:34][CH:33]=[CH:32][C:31]=3[C:36]3[N:40](C(C4C=CC=CC=4)(C4C=CC=CC=4)C4C=CC=CC=4)[N:39]=[N:38][N:37]=3)=[CH:26][CH:25]=2)[C:5]([C:12]([O:14][CH2:15][C:16]2[O:17][C:18](=[O:22])[O:19][C:20]=2[CH3:21])=[O:13])=[C:6]([C:8]([OH:11])([CH3:10])[CH3:9])[N:7]=1)[CH3:2]>C(O)(=O)C>[CH2:1]([C:3]1[N:4]([CH2:23][C:24]2[CH:29]=[CH:28][C:27]([C:30]3[CH:35]=[CH:34][CH:33]=[CH:32][C:31]=3[C:36]3[NH:40][N:39]=[N:38][N:37]=3)=[CH:26][CH:25]=2)[C:5]([C:12]([O:14][CH2:15][C:16]2[O:17][C:18](=[O:22])[O:19][C:20]=2[CH3:21])=[O:13])=[C:6]([C:8]([OH:11])([CH3:9])[CH3:10])[N:7]=1)[CH3:2]Participants
3
Procedure
Following a procedure similar to that described in Example 78(b), but using 1.90 g of (5-methyl -2-oxo-1,3-dioxolen-4-yl)methyl 2-ethyl-4-(1-hydroxy-1-methylethyl)-1-{4-[2-(trityltetrazole-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate [prepared as described in step (a) above] and 20 ml of 75% v/v aqueous acetic acid, 1.23 g of the title compound was obtained as a crystalline powder.
Sources & evidence
- ORD record
- ord-d77be81b924f48a89ef09b070acfc15f
- Source dataset
- uspto-grants-1997_07
- Patent number
- US05646171
Reaction notes
Loading…